Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats

详细信息	查看全文 | 推荐本文 |

• 作者：Zaquer S.M. Costa-Ferro^a ; ^b ; Bruno S.F. Souza^b ; ^c ; Marcos M.T. Leal^b ; Carla Martins Kaneto^b ; Carine Machado Azevedo^b ; Igor Campos da Silva^b ; ^d ; Milena B.P. Soares^b ; ^c ; Ricardo Ribeiro-dos-Santos^b ; Jaderson C. DaCosta^a ; ^{samuelgreggio@yahoo.com}
• 关键词：Temporal lobe epilepsy ; Bone marrow mononuclear cells ; Seizure frequency ; Neuronal loss ; Cytokines ; Pilocarpine
• 刊名：Neurobiology of Disease
• 出版年：2012
• 期刊代码：80_09699961
• 类别：neu
• 出版时间：May, 2012
• 卷：46
• 期：2
• 页码：302-313
• 文件大小：3424 K

摘要

Approximately 30%of patients with mesial temporal lobe epilepsy do not respond to treatment with antiepileptic drugs. We have previously shown that transplantation of mononuclear bone marrow cells (BMC) has an anticonvulsant effect in acute epilepsy. Here, we used pilocarpine to induce epilepsy in rats and studied the effects of BMC injected intravenously either at the onset of seizures or after 10 months of recurrent seizures. BMC effectively decreased seizure frequency and duration. In addition, decreased levels of proinflammatory cytokines (TNF-伪, IL-1尾 and IL-6) and increased levels of anti-inflammatory cytokine (IL-10) were observed in the brain and serum of BMC-treated rats. Transplants performed at seizure-onset protected against pilocarpine-induced neuronal loss and gliosis and stimulated the proliferation of new neurons in epileptic rats. Our data demonstrate that BMC transplantation has potent therapeutic effects and could be a potential therapy for clinically intractable epilepsies.